Medicina personalizada

diagnóstico genético de cardiopatías/canalopatías hereditarias

Translated title of the contribution: Personalized medicine: Genetic diagnosis for inherited cardiomyopathies/ channelopathies

Michael John Ackerman, Cherisse A. Marcou, David J. Tester

Research output: Contribution to journalArticle

Abstract

Major advances in the field of molecular genetics have expanded our ability to identify genetic substrates underlying the pathogenesis of various disorders that follow Mendelian inheritance patterns. Included among these disorders are the potentially lethal and heritable channelopathies and cardiomyopathies for which the underlying genetic basis has been identified and is now better understood. Clinical and genetic heterogeneity are hallmark features of these disorders, with thousands of gene mutations being implicated within these divergent cardiovascular diseases. Genetic testing for several of these heritable channelopathies and cardiomyopathies has matured from discovery to research-based genetic testing to clinically/commercially available diagnostic tests. The purpose of this review is to provide the reader with a basic understanding of human medical genetics and genetic testing in the context of cardiovascular diseases of the heart. We review the state of clinical genetic testing for the more common channelopathies and cardiomyopathies, discuss some of the pertinent issues that arise from genetic testing, and discuss the future of personalized medicine in cardiovascular disease.

Original languageSpanish
Pages (from-to)298-307
Number of pages10
JournalRevista Espanola de Cardiologia
Volume66
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Channelopathies
Precision Medicine
Genetic Testing
Cardiomyopathies
Cardiovascular Diseases
Medical Genetics
Inheritance Patterns
Genetic Heterogeneity
Routine Diagnostic Tests
Molecular Biology
Mutation
Research
Genes

Keywords

  • Cardiomyopathy
  • Channelopathies
  • Genetics
  • Ion channels

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Medicina personalizada : diagnóstico genético de cardiopatías/canalopatías hereditarias. / Ackerman, Michael John; Marcou, Cherisse A.; Tester, David J.

In: Revista Espanola de Cardiologia, Vol. 66, No. 4, 04.2013, p. 298-307.

Research output: Contribution to journalArticle

@article{b077f601727243f79d1a6c4dff5f7891,
title = "Medicina personalizada: diagn{\'o}stico gen{\'e}tico de cardiopat{\'i}as/canalopat{\'i}as hereditarias",
abstract = "Major advances in the field of molecular genetics have expanded our ability to identify genetic substrates underlying the pathogenesis of various disorders that follow Mendelian inheritance patterns. Included among these disorders are the potentially lethal and heritable channelopathies and cardiomyopathies for which the underlying genetic basis has been identified and is now better understood. Clinical and genetic heterogeneity are hallmark features of these disorders, with thousands of gene mutations being implicated within these divergent cardiovascular diseases. Genetic testing for several of these heritable channelopathies and cardiomyopathies has matured from discovery to research-based genetic testing to clinically/commercially available diagnostic tests. The purpose of this review is to provide the reader with a basic understanding of human medical genetics and genetic testing in the context of cardiovascular diseases of the heart. We review the state of clinical genetic testing for the more common channelopathies and cardiomyopathies, discuss some of the pertinent issues that arise from genetic testing, and discuss the future of personalized medicine in cardiovascular disease.",
keywords = "Cardiomyopathy, Channelopathies, Genetics, Ion channels",
author = "Ackerman, {Michael John} and Marcou, {Cherisse A.} and Tester, {David J.}",
year = "2013",
month = "4",
doi = "10.1016/j.recesp.2012.12.010",
language = "Spanish",
volume = "66",
pages = "298--307",
journal = "Revista Espanola de Cardiologia",
issn = "0300-8932",
publisher = "Ediciones Doyma, S.L.",
number = "4",

}

TY - JOUR

T1 - Medicina personalizada

T2 - diagnóstico genético de cardiopatías/canalopatías hereditarias

AU - Ackerman, Michael John

AU - Marcou, Cherisse A.

AU - Tester, David J.

PY - 2013/4

Y1 - 2013/4

N2 - Major advances in the field of molecular genetics have expanded our ability to identify genetic substrates underlying the pathogenesis of various disorders that follow Mendelian inheritance patterns. Included among these disorders are the potentially lethal and heritable channelopathies and cardiomyopathies for which the underlying genetic basis has been identified and is now better understood. Clinical and genetic heterogeneity are hallmark features of these disorders, with thousands of gene mutations being implicated within these divergent cardiovascular diseases. Genetic testing for several of these heritable channelopathies and cardiomyopathies has matured from discovery to research-based genetic testing to clinically/commercially available diagnostic tests. The purpose of this review is to provide the reader with a basic understanding of human medical genetics and genetic testing in the context of cardiovascular diseases of the heart. We review the state of clinical genetic testing for the more common channelopathies and cardiomyopathies, discuss some of the pertinent issues that arise from genetic testing, and discuss the future of personalized medicine in cardiovascular disease.

AB - Major advances in the field of molecular genetics have expanded our ability to identify genetic substrates underlying the pathogenesis of various disorders that follow Mendelian inheritance patterns. Included among these disorders are the potentially lethal and heritable channelopathies and cardiomyopathies for which the underlying genetic basis has been identified and is now better understood. Clinical and genetic heterogeneity are hallmark features of these disorders, with thousands of gene mutations being implicated within these divergent cardiovascular diseases. Genetic testing for several of these heritable channelopathies and cardiomyopathies has matured from discovery to research-based genetic testing to clinically/commercially available diagnostic tests. The purpose of this review is to provide the reader with a basic understanding of human medical genetics and genetic testing in the context of cardiovascular diseases of the heart. We review the state of clinical genetic testing for the more common channelopathies and cardiomyopathies, discuss some of the pertinent issues that arise from genetic testing, and discuss the future of personalized medicine in cardiovascular disease.

KW - Cardiomyopathy

KW - Channelopathies

KW - Genetics

KW - Ion channels

UR - http://www.scopus.com/inward/record.url?scp=84875421268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875421268&partnerID=8YFLogxK

U2 - 10.1016/j.recesp.2012.12.010

DO - 10.1016/j.recesp.2012.12.010

M3 - Article

VL - 66

SP - 298

EP - 307

JO - Revista Espanola de Cardiologia

JF - Revista Espanola de Cardiologia

SN - 0300-8932

IS - 4

ER -